生物类似药新进入者能否赢得竞赛？欧洲生物类似药市场揭示的下一竞争前沿

关于 chi9iua

This author has not written his bio yet.
But we are proud to say that chi9iua contributed 81 entries already.

日志 chi9iua

(English) Can New Entrants Win the Biosimilar Race? What Europe's Biosimilar Market Reveals About the Next Competitive Frontier

June 23, 2026/在： Corporate News, Story, Uncategorized/通过： chi9iua

鼎康生物在全球生物药制造创新峰会上发布下一代全球生物药制造愿景

June 10, 2026/在： Corporate News, News, Uncategorized/通过： chi9iua

[/av_two_third]

鼎康生物与大熊制药达成战略合作，共同推进度普利尤单抗生物类似药全球开发与商业化

June 1, 2026/在： Corporate News, News, Uncategorized/通过： chi9iua

(English) From AI Vision to AI Execution

May 15, 2026/在： Corporate News, Story, Uncategorized/通过： chi9iua

鼎康生物亮相BIO Equity Europe 2026——推动AI生物制药从概念走向现实

May 14, 2026/在： Corporate News, News, Uncategorized/通过： chi9iua

(English) Chime Biologics at BIO Equity Europe 2026 ---Turning AI into Biologics Reality Amid the New Global Biopharma Landscape

May 12, 2026/在： Uncategorized/通过： chi9iua

对不起，此内容只适用于English。 For the sake of viewer convenience, […]

(English) Chime Biologics Japan Online Roadshow

May 11, 2026/在： Event, NewsRoom, Uncategorized/通过： chi9iua

对不起，此内容只适用于English和日本語。 For the sake of viewer convenie […]

全球生物药制造创新峰会

April 24, 2026/在： Event, NewsRoom, Uncategorized/通过： chi9iua

在生物药制造中驾驭人工智能的力量

April 22, 2026/在： Corporate News, Story, Uncategorized/通过： chi9iua

从武汉出发，链接韩国生物医药创新-鼎康生物赋能韩国生物药产业新格局

April 17, 2026/在： Corporate News, News, Uncategorized/通过： chi9iua